CLE's on MedImmune v. Genentech

West Legalworks® is offering a webcast entitled: "Rethinking Patent License Agreements in the Wake of MedImmune v. Genentech" on February 6, 2007 from 12:00-1:30 PM (EST).  Speakers Brian Kacedon and Kathleen Daley will discuss patent license provisions and strategies in view of the MedImmune decision.  According to Thomson-West, the speakers will also address the following issues:

• Will MedImmune affect your existing license agreements, and if so, to what extent?
• What do licensees and licensors need to know for future negotiations and agreements?
• What license provisions are a must after MedImmune?
• How should you draft your license agreements in the future?
• How can licensees and licensors best protect their interests in light of this decision?
• How will MedImmune affect the ability of generic drug manufacturers to seek declaratory judgments?
• What questions has the Supreme Court left unanswered?

The registration fee for this webcast is $125.  Those interested in registering for the webcast, can do so here.

Strafford CLE Teleconferences is offering a telephone conference entitled: "MedImmune v. Genentech: Impact of the Supreme Court's Jan. 9 Decision on Patent Licenses" on February 14, 2007 from 1:00-2:30 PM (EST).  Speakers Michael O'Shea, Charles Baker, and David Segal will discuss the impact of the MedImmune decision on patent owners, licensees, and license agreements. According to Strafford, the speakers will also address the following questions:

• How has MedImmune shifted the balance of power between patent owners and licensees - and how can licensors protect their rights?
• How will MedImmune impact license negotiations and enforcement?
• What are the best practices for licensors to protect themselves from patent challenges by licensees?

A program outline for the teleconference can be obtained here.  The registration for the teleconference is $297.  Those interested in registering can do so here.

The ABA is offering a webcast entitled: "Potential Licensing Responses to MedImmune: The Supreme Court's Latest Word on Declaratory Judgment Actions Challenging Patent Validity" on February 20, 2007 from 1:00-2:30 PM (EST).  Speakers Monique Morneault, William Murray, and Lawrence Pope will discuss licensing approaches following the MedImmune decision.  The registration for this webcast ranges from $75 to $150.  Those interested in registering, can do so here.

Kevin Noonan's report on the MedImmune decision can be found here.